SCHEMBL3123431

SCHEMBL3123431

COc1ccc(CCC(N)=O)cc1S(C)(=O)=O

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.50
▸ CA1 P00915 2/20 0.46
▸ CA2 P00918 2/20 0.46
▸ CA9 Q16790 2/20 0.46
▸ CA14 Q9ULX7 2/20 0.46
▸ CA12 O43570 1/20 0.46
▸ CA5A P35218 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.44
▸ ATM Q13315 1/20 0.44
▸ ALOX5 P09917 1/20 0.43
▸ OR51E2 Q9H255 1/20 0.43
▸ AOC3 Q16853 1/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ LMNA P02545 2/20 0.43
▸ CYP19A1 P11511 2/20 0.43
▸ CA7 P43166 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3128947 0.93 SMN1; SMN2 (0.49) SMN1; SMN2CA1CA2CA9CA14
SCHEMBL3129382 0.89 ALOX5 (0.47) SMN1; SMN2CA1CA2CA9CA14
SCHEMBL1032004 0.83 KDM4E (0.62) CA1CA2CA9CA12KDM4E
SCHEMBL28176844 0.83 KDM4E (0.62) CA1CA2CA9CA12KDM4E
Hydrochloric Acid SCHEMBL10448977 0.82 KDM4E (0.61) CA1CA2CA9CA12KDM4E
SCHEMBL3131696 0.81 ALDH1A1 (0.46) CA1CA2KDM4EALOX5OR51E2
SCHEMBL3465918 0.78 SMN1; SMN2 (0.48) SMN1; SMN2CA2KDM4EKMT2AALDH1A1
SCHEMBL28780839 0.78 L3MBTL1 (0.49) LMNAALDH1A1
SCHEMBL14892303 0.78 HTT (0.54) KDM4EATMALOX5OR51E2LMNA
SCHEMBL4094627 0.78 CDK8 (0.55) SMN1; SMN2CA1CA2KDM4EATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010036632-A1 AZAINDAZOLE COMPOUNDS AS CCR1 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-04-01 — — WO disclosed
Send feedback